Education
About Us
Working with TipRanks
Follow Us
Vireo Growth Inc (VREOF)
:VREOF
VREOF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.23 - $0.69
Previous CloseN/A
Volume345.43K
Average Volume (3M)163.47K
Market Cap
$150.91M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)77.03M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding339,475,280
10 Day Avg. Volume149,782
30 Day Avg. Volume163,471
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.55Price Target Upside30.95% Upside
Rating ConsensusHold
Number of Analyst Covering0
Vireo Growth News
PremiumCompany Announcements
Vireo Growth Completes Acquisition of Deep Roots
PremiumCompany Announcements
Vireo Growth Completes Acquisition of Deep Roots Holdings
PremiumCompany Announcements
Vireo Growth Inc. Completes Acquisition of Proper Brands in Missouri
PremiumCompany Announcements
Vireo Growth Completes Key Acquisitions to Boost Profitability
PremiumCompany Announcements
Goodness Growth Holdings Reports Q1 2025 Earnings
PremiumCompany Announcements
Goodness Growth Holdings Inc. Earnings Call HighlightsPremiumCompany Announcements
Vireo Growth Inc. Reports Q1 2025 Results and Prepares for Strategic MergersOptions Prices
Currently, No data available
---
Ownership Overview
VREOF FAQ
What was Vireo Growth Inc’s price range in the past 12 months?
Vireo Growth Inc lowest stock price was $0.23 and its highest was $0.69 in the past 12 months.
What is Vireo Growth Inc’s market cap?
Vireo Growth Inc’s market cap is $150.91M.
When is Vireo Growth Inc’s upcoming earnings report date?
Vireo Growth Inc’s upcoming earnings report date is Aug 07, 2025 which is in 53 days.
How were Vireo Growth Inc’s earnings last quarter?
Vireo Growth Inc released its earnings results on May 09, 2025. The company reported -$0.018 earnings per share for the quarter, beating the consensus estimate of -$0.02 by $0.002.
Is Vireo Growth Inc overvalued?
According to Wall Street analysts Vireo Growth Inc’s price is currently Undervalued.
Does Vireo Growth Inc pay dividends?
Vireo Growth Inc does not currently pay dividends.
What is Vireo Growth Inc’s EPS estimate?
Vireo Growth Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vireo Growth Inc have?
Vireo Growth Inc has 339,475,280 shares outstanding.
What happened to Vireo Growth Inc’s price movement after its last earnings report?
Vireo Growth Inc reported an EPS of -$0.018 in its last earnings report, beating expectations of -$0.02. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Vireo Growth Inc?
Currently, no hedge funds are holding shares in VREOF
Vireo Growth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.55 (30.95% Upside)
$0.55 (30.95% Upside)
Blogger Sentiment
Bullish
VREOF Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $20.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.18%
12-Months-Change
Fundamentals
Return on Equity
-199.59%
Trailing 12-Months
Asset Growth
45.14%
Trailing 12-Months
Company Description
Vireo Growth Inc
Vireo Health International, Inc. is a holding company, which engages in the cultivation, production, and sale of medical cannabis. Its products include medical marijuana extracts in the form of oils, vaporizers, and capsules. The company was founded on November 23, 2004 and is headquartered in Minneapolis, MN.
VREOF Company Deck
VREOF Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call conveyed a generally positive outlook, with several highlights including revenue growth, improved gross margin, and a strong financial position. The company is progressing well on merger transactions that are expected to enhance profitability. However, there were some lowlights such as sequential revenue decline and a decrease in property income.Read More>Technical Analysis
ZYUS Life Sciences
―
MTL Cannabis
―
Leef Brands
―
Refined Energy
―
Simply Solventless Concentrates Ltd
―